CLINICAL_TRIALS
ClinicalTrials.gov record update
Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers, Not Eligible for Initial Sequencing in Clinical Routine and Selected From the First Line in Molecular Tumour Board.
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06958224
- Title field or adapter rule
- {'original_value': 'Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers, Not Eligible for Initial Sequencing in Clinical Routine and Selected From the First Line in Molecular Tumour Board.', 'source_field': 'protocolSection.identificationModule.officialTitle'}
- Ingested At
- 2026-10-31T23:27:22.709569+00:00
- Published At
- 2026-10-22T00:00:00+00:00
- Record Updated At
- 2026-10-22
- Source Retrieved At
- 2026-10-31T22:17:25.750886+00:00
- Timestamp Basis
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
- Date limitation
- ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Breast Cancer", "Liver Cancer", "Pancreatic Ductal Adenocarcinoma"]- protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-22", "type": "ACTUAL"}- protocolSection.identificationModule.nctId
"NCT06958224"- protocolSection.identificationModule.officialTitle
"Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers, Not Eligible for Initial Sequencing in Clinical Routine and Selected From the First Line in Molecular Tumour Board."- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct
null
Study condition terms
Interventions recorded in this study
- {'armGroupLabels': ['Large Sequential multigene sequencing according to Plan France Medecine Genomique 2025', 'Large and early multigene sequencing'], 'description': 'Part 1 sequential multi-gene sequencing (Simple NGS),\n\n* Multi-gene DNA sequencing (43 genes panel corresponding to the most frequently targeted molecular alterations)\n* And if no contributive:\n\nPart 2: randomized study between two sequential approaches\n\n\\- Experimental arm: early Multi-gene DNA sequencing (638 genes panel) Multi-gene RNA sequencing (ARCHER panel)\n\n1. MMR status in molecular biology\n2. \\- Tumour Mutational Burden\n\n * Control arm: after 1st line escape, according to Plan France Medecine Genomique 2025 In the Part 2, a new biopsy could be proposed if necessary', 'name': 'Large and early multigene sequencing', 'type': 'GENETIC'} (protocolSection.armsInterventionsModule.interventions[])
An intervention appearing in a study record does not establish an effect or an approved use.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.